BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

OrbusNeich 

5th Floor, Neich Tower
128 Gloucester Road
Wanchai      Hong Kong
Phone: 852-2802-2288 Fax: 852-2507-3532


SEARCH JOBS




Industry
Biotechnology






 Company News
OrbusNeich Initiates HARMONEE Study In Japan To Evaluate The COMBO™ Dual Therapy Stent 2/26/2014 11:41:50 AM    More...
OrbusNeich's COMBO™ Dual Therapy Stent Shows Excellent Early Healing and Durable Outcomes Out to 24 Months 10/30/2013 10:07:44 AM    More...
Clinical Data for OrbusNeich's COMBO™ Dual Therapy Stent to Be Presented at TCT 2013 10/22/2013 9:11:34 AM    More...
First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich's COMBO Dual Therapy Stent™ in Routine Practice 8/6/2013 10:22:10 AM    More...
OrbusNeich Launches World's First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents 5/28/2013 9:47:57 AM    More...
OrbusNeich Release: Delayed Healing of Coronary Artery Following Implantation of Drug Eluting Stents, Increasing Risk of Thrombosis, is a Top Concern of Interventional Cardiologists, International Survey Shows 5/21/2013 10:03:46 AM    More...
OrbusNeich's Genous™ Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients 5/20/2013 10:15:55 AM    More...
OrbusNeich Release: COMBO Dual Therapy Stent™ Clinical Results to be Featured at EuroPCR 2013 5/13/2013 7:43:55 AM    More...
OrbusNeich Enforces Injunction Against Boston Scientific Corporation (BSX) in Germany 5/7/2013 10:01:51 AM    More...
Data Published in JACC: Cardiovascular Interventions Show That OrbusNeich's COMBO Dual Therapy Stent™ Reaches Primary Study Endpoint and is Effective in Controlling Neointimal Proliferation 4/17/2013 9:10:29 AM    More...
1234567